Jakob Tellgren recently returned from MSD’s US headquarters to his home country of Sweden to take the helm of the Nordic and Baltic countries. He shares the importance of Sweden and the Nordics for the group and his plans to continue driving the outstanding performance of the affiliate while bringing value to both patients and the healthcare system at large. He also talks about how MSD leverages the excellent Swedish academic ecosystem through collaboration with the Karolinska Institute on patient-centric outcomes-based research.
Sweden continues to be an ideal environment for clinical research, early launches and follow-up of new vaccines
